Homebiotech

biotech

biotech

Cancer cells hijack a fatty acid to escape immune attack in liver metastases

Jim Cornall - August 6, 2026

biotech

Collaboration aims to develop new class of medicines for in vivo CAR-T

Jim Cornall - August 5, 2026

biotech

Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples

Jim Cornall - August 5, 2026

biotech

White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease

Jim Cornall - August 4, 2026

biotech

Base to Base biotech podcast 31: Exhilarating enzymes and super socks

Jim Cornall - October 17, 2025

biotech

New company to develop psoriasis monoclonal antibody

Jim Cornall - October 15, 2025

biotech

DNA nanospring could boost disease diagnosis

Jim Cornall - October 15, 2025

biotech

Health Canada approves first treatment for Duchenne muscular dystrophy

Jim Cornall - October 14, 2025

biotech

Neuroblastoma treatment receives Orphan Drug Designation

Jim Cornall - October 13, 2025

biotech

Base to Base biotech podcast 30: Life sciences in Lithuania

Jim Cornall - October 9, 2025

biotech

Encouraging results from Canavan disease trial

Jim Cornall - October 9, 2025

biotech

Collaboration to address CAR-T cell therapy for brain cancer

Jim Cornall - October 9, 2025

1...626364...94 Page 63 of 94

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Cancer cells hijack a fatty acid to escape immune attack in liver metastases

Jim Cornall - August 6, 2026 0

Liver metastases are among the most common and deadly forms of cancer spread. Now, researchers at VIB and KU Leuven, with international collaborators, have...

Collaboration aims to develop new class of medicines for in vivo CAR-T

biotech Jim Cornall - August 5, 2026 0

Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples

biotech Jim Cornall - August 5, 2026 0

White paper looks at early clinical development of B-cell depletion therapies in autoimmune disease

biotech Jim Cornall - August 4, 2026 0

3D genome mapping in rare immune cells reveals new Crohn’s disease genes

biotech Jim Cornall - August 4, 2026 0